glaucoma and semaglutide may cause blindness—US study warning adds to growing debate on rare side effect GLP-1 RA Weight Loss Drugs
Description
The GLP-1 NAION vision-loss MDL hit 146 cases on the July JPML report up 70% in two months as the GI-injury MDL heads to Rule 702 hearings September 10-18.

Thyroid disorders affect millions seeking weight loss treatment

This review examines how Midi Health structures its provider assessment, genetic screening options, and medication access compared to precision-focused alternatives like PlexusDx

PlexusDx explains the physiologic mechanism and what clinical evidence reveals about cardiovascular safety

AstraZeneca Targeting $80B revenue by 2030 20+ new medicines planned this decade Strong wins in oncology & rare diseases 4